In a non‑blinded study of six healthy volunteers, 5,6‑methylenedioxy‑2‑aminoindane (MDAI) produced subjective effects comparable with 125 mg MDMA and raised blood pressure and endocrine markers (cortisol, prolactin) but, unlike MDMA, did not increase heart rate or body temperature. MDAI was well tolerated and remained detectable in serum and urine for several days, warranting further clinical investigation of potential medicinal properties.
- Published
- Journal
- Drug Testing and Analysis
- Authors
- Angerer, V., Schmid, Y., Franz, F., Gnann, H., Speer, J. M., Gnann, A., Helmecke, S., Buchwald, A., Brandt, S. D., Passie, T., Liechti, M. E., Auwärter, V.